Cargando…
Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect
Hepatocellular carcinoma (HCC) is a tumor that exhibits glucometabolic reprogramming, with a high incidence and poor prognosis. Usually, HCC is not discovered until an advanced stage. Sorafenib is almost the only drug that is effective at treating advanced HCC, and promising metabolism-related thera...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381782/ https://www.ncbi.nlm.nih.gov/pubmed/32765096 http://dx.doi.org/10.2147/CMAR.S258196 |